News
Transverse Medical announced that it completed its Series B2 financing round worth more than $10 million in new capital.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback